Pharmacyclics
E2013247
UNEXPLORED
Pharmacyclics is a biopharmaceutical company best known for developing the cancer drug ibrutinib (Imbruvica) and focusing on innovative treatments for hematologic malignancies.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Pharmacyclics canonical | 2 |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.